Sep 09, 2020 / 02:50PM GMT
Evan Arthur Stover - Robert W. Baird & Co. Incorporated, Research Division - Senior Research Associate
All right. So we should be live. This is the 10:50 session. My name is Evan Stover. I'm an analyst at Baird, covering pharma services and the health care supply chain. With us, we have Catalent. For those of you that don't know, Catalent is a leading contract development and manufacturing organization for the biopharma industry. Very exciting secular growth story before the pandemic and also now playing a key role in COVID vaccine and therapeutics production. Presenting this morning, we have Wetteny Joseph, Senior Vice President and CFO, experienced in many roles with the company, dating back to 2008. Additionally, we have Paul Surdez, Vice President of Investor Relations.
Wetteny is going to give some prepared remarks before our Q&A. If you have questions, there should be an area to submit them in the presentation. And with that, I'll hand it over to Wetteny.
Wetteny N. Joseph - Catalent, Inc. - Senior VP & CFO
Thank you, Evan. As I may
Catalent Inc at Robert W Baird Global Healthcare Conference (Virtual) Transcript
Sep 09, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers